Chris Womack
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Fibroblast Growth Factor Research 3
- Oncology 12
- PARP inhibition in cancer therapy 4
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Neil Gray (5 shared papers)Neil R. Smith (3 shared papers)Dawn Baker (3 shared papers)Ruth Swann (2 shared papers)Martin Jenkins (2 shared papers)Shethah Morgan (3 shared papers)Dugal Heath (1 shared paper)Kirsty Ratcliffe (1 shared paper)
- Journals
- Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (4 papers)Journal of Clinical Pathology (4 papers)British Journal of Cancer (3 papers)
- Partner nations
- United KingdomUnited StatesBrazil
In The Last Decade
Chris Womack
34 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Oncology 522
- Cancer Research 166
- Gastroenterology 46
- Reproductive Medicine 65
- Pulmonary and Respiratory Medicine 225
Countries citing papers authored by Chris Womack
This map shows the geographic impact of Chris Womack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Womack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Womack more than expected).
Fields of papers citing papers by Chris Womack
This network shows the impact of papers produced by Chris Womack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Womack. The network helps show where Chris Womack may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Womack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 198 | |
| 2 | 2018 | 173 | |
| 3 | 2014 | 156 | |
| 4 | 2013 | 113 | |
| 5 | 2009 | 75 | |
| 6 | 2014 | 68 | |
| 7 | 2013 | 57 | |
| 8 | 2011 | 48 | |
| 9 | 1987 | 40 | |
| 10 | 2014 | 35 | |
| 11 | 1988 | 35 | |
| 12 | 1985 | 27 | |
| 13 | 2013 | 22 | |
| 14 | 2014 | 21 | |
| 15 | 2015 | 21 | |
| 16 | 2013 | 20 | |
| 17 | Human research tissue banks in the UK National Health Service: laws, ethics, controls and constraints. | 2000 | 15 |
| 18 | 1999 | 15 | |
| 19 | 2014 | 15 | |
| 20 | 2010 | 14 |
About Chris Womack
Chris Womack is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Physiology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Biomedical Ethics and Regulation (4 papers), Cancer Genomics and Diagnostics (3 papers), HER2/EGFR in Cancer Research (3 papers), Fibroblast Growth Factor Research (3 papers), Ethics in Clinical Research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (522 citations), Cancer Research (166 citations), Gastroenterology (46 citations), Reproductive Medicine (65 citations) and Pulmonary and Respiratory Medicine (225 citations). Chris Womack has collaborated with scholars based in United Kingdom, United States and Brazil. Frequent co-authors include Neil Gray, Neil R. Smith, Dawn Baker, Ruth Swann, Martin Jenkins, Shethah Morgan, Dugal Heath, Kirsty Ratcliffe, Anderson J. Ryan and Susan Ashton. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Journal of Clinical Pathology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.